Signadori Bio
Signadori Bio is the next-generation cellular immunotherapy for cancer cure.This has culminated in the creation of a groundbreaking biotech venture in the cell and gene space that is set to advance innovative approaches in oncology.
Signadori Bio is the next-generation cellular immunotherapy for cancer cure.This has culminated in the creation of a groundbreaking biotech venture in the cell and gene space that is set to advance innovative approaches in oncology.
Signadori Bio has raised $13.0M across 1 round. Its most recent round was a Seed of $13.0M in May 2026. Full funding history, investors, and team are detailed below.
Funding history
1 round on record.
Unlock the lead investor and full details for this round.
People
Founders, executives, and decision-makers — sourced and refreshed weekly.
See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.
Signadori Bio is featured in
Similar companies
Beams is a producer of medical devices for cancerology based on the use of particles β.
Padoa is an occupational health software firm that develops a tool for monitoring the health of employees. Its service provides occupational health teams with a host of tools ranging from managing appointments, general administration, staff management, individual employee follow-ups, and the design of prevention policies in the workplace. The company aims to improve the health of millions of workers by applying innovation and technology to occupational health. It was founded in 2016 and is based in
CILcare specializes in providing drug solutions for hearing and ear disorders.
MEDIAN Technologies develops medical imaging software and services dedicated to oncology clinical trials, cancer screening, and clinical practice. The company standardizes and automates the interpretation of medical images in oncology to optimize the diagnosis of cancer patients and the assessment of their response to therapy. The company serves two primary markets: drug development and patient care. MEDIAN Technologies has a strategic partnership with a contract research organization to offer integrated imaging services for clinical trials to biopharma sponsors worldwide, and a strategic partnership with Canon to develop new imaging technologies, and to address the patient care market. MEDIAN Technologies was founded in 2002 and is based in Sophia-Antipolis, France.
noa is a digital fitness and wellness company that offers premium, structured training programs for strength, pilates, and overall well-being through expert coaching and technology-driven experiences.
Semeia offers patient monitoring solution designed to support medical followup of patients, remotely and in consultation. They use deep learning technologies to estimate the risk of the occurrence of an adverse event or disruption in the patients care pathway.
Axomove is an e-wellbeing application that spends significant time in video actual activities.
Parallel helps coding agent works side by side with hospital teams to deliver faster and more accurate medical coding.
May Health has created a new solution for infertility caused by Polycystic Ovary Syndrome (PCOS) that is aimed at giving patients a more natural and less medicalized approach to pregnancy. Their goal is to help PCOS patients regain ovulation through a one-time, minimally invasive treatment that can be done in a clinic setting without the need for general anesthesia. The procedure is performed transvaginally under ultrasound guidance, using the same minimally invasive approach commonly used for IVF by fertility specialists.
MedinCell is an injectable slow-release drug specialist company.
Charles helps men regain control over their daily health concerns by starting with their personal health.
Lifeaz saves lives by developing a new generation of connected, simpler, more reliable and smarter defibrillators.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.